ATE332693T1 - Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose - Google Patents
Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibroseInfo
- Publication number
- ATE332693T1 ATE332693T1 AT01910188T AT01910188T ATE332693T1 AT E332693 T1 ATE332693 T1 AT E332693T1 AT 01910188 T AT01910188 T AT 01910188T AT 01910188 T AT01910188 T AT 01910188T AT E332693 T1 ATE332693 T1 AT E332693T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- liver
- pharmaceutical composition
- cirrhosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20000010540 | 2000-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332693T1 true ATE332693T1 (de) | 2006-08-15 |
Family
ID=36776473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01910188T ATE332693T1 (de) | 2000-03-02 | 2001-03-02 | Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1263435B1 (de) |
JP (1) | JP4226246B2 (de) |
CN (1) | CN1218698C (de) |
AT (1) | ATE332693T1 (de) |
AU (1) | AU2001237768A1 (de) |
BR (1) | BR0108732A (de) |
DE (1) | DE60121426T2 (de) |
ES (1) | ES2267722T3 (de) |
RU (1) | RU2250768C2 (de) |
WO (1) | WO2001064215A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030067935A (ko) * | 2002-02-09 | 2003-08-19 | 김상건 | 올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물 |
KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
KR100604261B1 (ko) * | 2004-10-11 | 2006-07-28 | 재단법인서울대학교산학협력재단 | 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-c]피리딘-3-티온계 화합물 |
EP2026810A2 (de) | 2006-05-11 | 2009-02-25 | Patrick T. Prendergast | Zusammensetzungen und verfahren zur modulation des immunsystems |
-
2001
- 2001-03-02 RU RU2002126216/15A patent/RU2250768C2/ru not_active IP Right Cessation
- 2001-03-02 AT AT01910188T patent/ATE332693T1/de not_active IP Right Cessation
- 2001-03-02 JP JP2001563112A patent/JP4226246B2/ja not_active Expired - Fee Related
- 2001-03-02 BR BR0108732-0A patent/BR0108732A/pt not_active Application Discontinuation
- 2001-03-02 DE DE60121426T patent/DE60121426T2/de not_active Expired - Lifetime
- 2001-03-02 ES ES01910188T patent/ES2267722T3/es not_active Expired - Lifetime
- 2001-03-02 CN CNB018059627A patent/CN1218698C/zh not_active Expired - Fee Related
- 2001-03-02 WO PCT/KR2001/000320 patent/WO2001064215A1/en active IP Right Grant
- 2001-03-02 EP EP01910188A patent/EP1263435B1/de not_active Expired - Lifetime
- 2001-03-02 AU AU2001237768A patent/AU2001237768A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2267722T3 (es) | 2007-03-16 |
BR0108732A (pt) | 2002-12-17 |
JP4226246B2 (ja) | 2009-02-18 |
RU2002126216A (ru) | 2004-03-20 |
RU2250768C2 (ru) | 2005-04-27 |
CN1407891A (zh) | 2003-04-02 |
AU2001237768A1 (en) | 2001-09-12 |
EP1263435A4 (de) | 2004-08-11 |
DE60121426T2 (de) | 2007-02-22 |
EP1263435B1 (de) | 2006-07-12 |
DE60121426D1 (de) | 2006-08-24 |
CN1218698C (zh) | 2005-09-14 |
JP2004538239A (ja) | 2004-12-24 |
EP1263435A1 (de) | 2002-12-11 |
WO2001064215A1 (en) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE234634T1 (de) | Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff | |
ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
RS20110578A2 (en) | MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
DE60334773D1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
HUP0302508A3 (en) | Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions | |
DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
BG106155A (en) | Novel derivatives and analogues of galanthamin | |
DE69919533D1 (de) | Proteinhaltige arzneimittel | |
DE50115451D1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
CA2473202A1 (en) | Pharmaceutical composition for regeneration of cirrhotic liver | |
ATE400277T1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
MY141506A (en) | Virus therapeutic drug | |
DE60121426D1 (de) | Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
ATE404192T1 (de) | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
GEP20043377B (en) | Pharmaceutical Complex | |
DE60107900D1 (de) | Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem | |
DK1492539T3 (da) | Statin-terapi til forögelse af kognitiv funktion | |
DE602004025103D1 (de) | Heilkräuterzusammensetzung zur Behandlung von AIDS | |
DE602004029993D1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
EP1157617A3 (de) | Verwendung von Alpha-Keto Enamine Derivate als Zutaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |